0001162956-14-000005.txt : 20141120
0001162956-14-000005.hdr.sgml : 20141120
20141120171021
ACCESSION NUMBER: 0001162956-14-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141118
FILED AS OF DATE: 20141120
DATE AS OF CHANGE: 20141120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERMILLION, INC.
CENTRAL INDEX KEY: 0000926617
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 330595156
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
BUSINESS PHONE: 512-519-0400
MAIL ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
FORMER COMPANY:
FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC
DATE OF NAME CHANGE: 20000316
FORMER COMPANY:
FORMER CONFORMED NAME: ABIOTIC SYSTEMS
DATE OF NAME CHANGE: 19950407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAFRANCE JAMES T
CENTRAL INDEX KEY: 0001162956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34810
FILM NUMBER: 141239709
MAIL ADDRESS:
STREET 1: 1910 INNOVATION PARK DR
CITY: TUCSON
STATE: AZ
ZIP: 85737
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-11-18
0
0000926617
VERMILLION, INC.
VRML
0001162956
LAFRANCE JAMES T
12117 BEE CAVES RD
BUILDING THREE, SUITE 100
AUSTIN
TX
78738
1
1
0
0
President & Chief Exec Officer
Common Stock
2014-11-18
4
P
0
29940
1.4
A
38440
D
Common Stock
2014-11-19
4
P
0
11675
1.5
A
50115
D
The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.26 to $1.50. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.44 to $1.51. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ James LaFrance
2014-11-20